Cargando…

Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery

Artificial intelligence (AI) has permeated various sectors, including the pharmaceutical industry and research, where it has been utilized to efficiently identify new chemical entities with desirable properties. The application of AI algorithms to drug discovery presents both remarkable opportunitie...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Ri, Yoon, Hongryul, Kim, Gahee, Lee, Hyundo, Lee, Yoonji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537003/
https://www.ncbi.nlm.nih.gov/pubmed/37765069
http://dx.doi.org/10.3390/ph16091259
_version_ 1785113000942764032
author Han, Ri
Yoon, Hongryul
Kim, Gahee
Lee, Hyundo
Lee, Yoonji
author_facet Han, Ri
Yoon, Hongryul
Kim, Gahee
Lee, Hyundo
Lee, Yoonji
author_sort Han, Ri
collection PubMed
description Artificial intelligence (AI) has permeated various sectors, including the pharmaceutical industry and research, where it has been utilized to efficiently identify new chemical entities with desirable properties. The application of AI algorithms to drug discovery presents both remarkable opportunities and challenges. This review article focuses on the transformative role of AI in medicinal chemistry. We delve into the applications of machine learning and deep learning techniques in drug screening and design, discussing their potential to expedite the early drug discovery process. In particular, we provide a comprehensive overview of the use of AI algorithms in predicting protein structures, drug–target interactions, and molecular properties such as drug toxicity. While AI has accelerated the drug discovery process, data quality issues and technological constraints remain challenges. Nonetheless, new relationships and methods have been unveiled, demonstrating AI’s expanding potential in predicting and understanding drug interactions and properties. For its full potential to be realized, interdisciplinary collaboration is essential. This review underscores AI’s growing influence on the future trajectory of medicinal chemistry and stresses the importance of ongoing synergies between computational and domain experts.
format Online
Article
Text
id pubmed-10537003
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105370032023-09-29 Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery Han, Ri Yoon, Hongryul Kim, Gahee Lee, Hyundo Lee, Yoonji Pharmaceuticals (Basel) Review Artificial intelligence (AI) has permeated various sectors, including the pharmaceutical industry and research, where it has been utilized to efficiently identify new chemical entities with desirable properties. The application of AI algorithms to drug discovery presents both remarkable opportunities and challenges. This review article focuses on the transformative role of AI in medicinal chemistry. We delve into the applications of machine learning and deep learning techniques in drug screening and design, discussing their potential to expedite the early drug discovery process. In particular, we provide a comprehensive overview of the use of AI algorithms in predicting protein structures, drug–target interactions, and molecular properties such as drug toxicity. While AI has accelerated the drug discovery process, data quality issues and technological constraints remain challenges. Nonetheless, new relationships and methods have been unveiled, demonstrating AI’s expanding potential in predicting and understanding drug interactions and properties. For its full potential to be realized, interdisciplinary collaboration is essential. This review underscores AI’s growing influence on the future trajectory of medicinal chemistry and stresses the importance of ongoing synergies between computational and domain experts. MDPI 2023-09-06 /pmc/articles/PMC10537003/ /pubmed/37765069 http://dx.doi.org/10.3390/ph16091259 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Han, Ri
Yoon, Hongryul
Kim, Gahee
Lee, Hyundo
Lee, Yoonji
Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery
title Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery
title_full Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery
title_fullStr Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery
title_full_unstemmed Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery
title_short Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery
title_sort revolutionizing medicinal chemistry: the application of artificial intelligence (ai) in early drug discovery
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537003/
https://www.ncbi.nlm.nih.gov/pubmed/37765069
http://dx.doi.org/10.3390/ph16091259
work_keys_str_mv AT hanri revolutionizingmedicinalchemistrytheapplicationofartificialintelligenceaiinearlydrugdiscovery
AT yoonhongryul revolutionizingmedicinalchemistrytheapplicationofartificialintelligenceaiinearlydrugdiscovery
AT kimgahee revolutionizingmedicinalchemistrytheapplicationofartificialintelligenceaiinearlydrugdiscovery
AT leehyundo revolutionizingmedicinalchemistrytheapplicationofartificialintelligenceaiinearlydrugdiscovery
AT leeyoonji revolutionizingmedicinalchemistrytheapplicationofartificialintelligenceaiinearlydrugdiscovery